Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07348055 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of GR1803 in Systemic Lupus Erythematosus

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date changed from estimate of Dec 31, 2025 to Feb 2, 2026v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
to evaluate the safety and efficacy of GR1803 in the treatment of patients with systemic lupus erythematosus
Trial Details
NCT Number NCT07348055
Lead Sponsor Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Conditions
(from sponsor)		 Systemic Lupus Erthematosus, Auto Immune Disease
Related terms Lupus Erythematosus, Systemic
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov